In Reply We thank Yuji and Yuji for their thoughtful comments regarding our study examining the association between baseline patient-reported fatigue and treatment-related toxic effects.
JAMA Oncology published a clinical update in Oncology on 23 Apr 2026.
The item focuses on Reassessing Treatment Outcomes Following Immune-Related Adverse Events—Reply.
Review the original article for the full source wording and details.